Left Ventricular Hypertrophy Geometry and Vascular Calcification Co-Modify the Risk of Cardiovascular Mortality in Patients with End-Stage Kidney Disease: A Retrospective Cohort Study

Aim: Patients with end-stage kidney disease (ESKD) have an unparalleled risk of left ventricular hypertrophy (LVH) and vascular calcification (VC), both of which introduce excessive cardiovascular risk. However, it remains unclear whether LVH geometry co-modulates cardiovascular outcomes with VC in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Chia-Ter, Liao, Min-Tser, Wu, Chung-Kuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499460/
https://www.ncbi.nlm.nih.gov/pubmed/36567124
http://dx.doi.org/10.5551/jat.63870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499460/
https://www.ncbi.nlm.nih.gov/pubmed/36567124
http://dx.doi.org/10.5551/jat.63870

Ejemplares similares